Literature DB >> 222803

Assay of human interferon in Vero cells by several methods.

P C Ferreira, M L Peixoto, M A Silva, R R Golgher.   

Abstract

Four methods for the assay of human interferon in Vero cells were compared based on the inhibition of viral cytopathic effect (CPE) in tubes, the inhibition of CPE in microplates, the reduction of plaques, and the inhibition of quantitative hemadsorption. For inhibition of CPE, Sindbis virus, vesicular stomatitis virus, poliovirus type 2, and vaccinia virus were used for challenge. In the plaque reduction method, Sindbis virus, vesicular stomatitis virus, and poliovirus were employed, and Newcastle disease virus was used in the quantitative hemadsorption assay. Sindbis virus was most susceptible to interferon in those tests measuring inhibition of CPE, but vesicular stomatitis virus was as sensitive in the plaque reduction method. Highest titers of interferon were recorded in microplates, especially with Sindbis virus as the challenge agent, followed by the quantitative inhibition assay. The CPE inhibition method was the simplest, and the quantitative hemadsorption assay was the most rapid to perform. Reproducibilities, as shown by the coefficient of variation, were 15, 39, and 59% for plaque reduction, CPE inhibition in tubes, and CPE inhibition in microplates, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222803      PMCID: PMC273056          DOI: 10.1128/jcm.9.4.471-475.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  QUANTITATIVE HAEMADSORPTION, A NEW ASSAY TECHNIQUE. I. ASSAY OF INTERFERON.

Authors:  N B FINTER
Journal:  Virology       Date:  1964-12       Impact factor: 3.616

2.  Metamorphosis of human amnion cells induced by preparations of interferon.

Authors:  I GRESSER
Journal:  Proc Natl Acad Sci U S A       Date:  1961-11-15       Impact factor: 11.205

3.  A sensitive interferon assay for many species of cells: encephalomyocarditis virus hemagglutinin yield reduction.

Authors:  P Jameson; M A Dixon; S E Grossberg
Journal:  Proc Soc Exp Biol Med       Date:  1977-06

4.  Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect.

Authors:  N H McManus
Journal:  Appl Environ Microbiol       Date:  1976-01       Impact factor: 4.792

5.  A microplaque reduction assay for human and mouse interferon.

Authors:  J B Campbell; T Grunberger; M A Kochman; S L White
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

6.  Improved assays for a variety of interferons. 1.

Authors:  H K Oie; C E Buckler; C P Uhlendorf; D A Hill; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

7.  A micro assay for mouse and human interferon.

Authors:  H Dahl; M Degré
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

8.  Sensitivity of human cell strains to interferon.

Authors:  C M Siewers; C E John; D N Medearis
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

9.  The neuraminidase yield-reduction bioassay of human other interferons.

Authors:  J J Sedmak; S E Grossberg; P Jameson
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

10.  Factors affecting the sensitivity of different viruses to interferon.

Authors:  J V Hallum; H R Thacore; J S Youngner
Journal:  J Virol       Date:  1970-08       Impact factor: 5.103

View more
  12 in total

1.  RNA interference inhibits yellow fever virus replication in vitro and in vivo.

Authors:  Carolina C Pacca; Adriana A Severino; Adriano Mondini; Paula Rahal; Solange G P D'avila; José Antonio Cordeiro; Mara Correa Lelles Nogueira; Roberta V M Bronzoni; Maurício L Nogueira
Journal:  Virus Genes       Date:  2009-01-25       Impact factor: 2.332

2.  Species-independent bioassay for sensitive quantification of antiviral type I interferons.

Authors:  Thomas Kuri; Matthias Habjan; Nicola Penski; Friedemann Weber
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

3.  Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Øyvind Haugland; Inderjit S Marjara; Øystein Evensen
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

4.  Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.

Authors:  Patricia V Aguilar; Slobodan Paessler; Anne-Sophie Carrara; Samuel Baron; Joyce Poast; Eryu Wang; Abelardo C Moncayo; Michael Anishchenko; Douglas Watts; Robert B Tesh; Scott C Weaver
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Affinity chromatography of primary human amnion interferon.

Authors:  P C Ferreira; M Paucker; R R Golgher; K Paucker
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

6.  The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells.

Authors:  Celeste M Newby; Leah Sabin; Andrew Pekosz
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

7.  Suppression of host gene expression by nsp1 proteins of group 2 bat coronaviruses.

Authors:  Yukinobu Tohya; Krishna Narayanan; Wataru Kamitani; Cheng Huang; Kumari Lokugamage; Shinji Makino
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

8.  Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells.

Authors:  Krishna Narayanan; Cheng Huang; Kumari Lokugamage; Wataru Kamitani; Tetsuro Ikegami; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

9.  Characterization of ATI, TK and IFN-alpha/betaR genes in the genome of the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus.

Authors:  J T Marques; G D Trindade; F G Da Fonseca; J R Dos Santos; C A Bonjardim; P C Ferreira; E G Kroon
Journal:  Virus Genes       Date:  2001-12       Impact factor: 2.198

10.  Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis.

Authors:  Danilo Bretas de Oliveira; Gabriel Magno de Freitas Almeida; Antônio Carlos Martins Guedes; Flávia Patrícia Sena Teixeira Santos; Claudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Int J Rheumatol       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.